The effectiveness of various gargle formulations and salt water against SARS-CoV-2

Tiong, Vunjia and Hassandarvish, Pouya and Abu Bakar, Sazaly and Mohamed, Nurul Azmawati and Sulaiman, Wan Shahida Wan and Baharom, Nizam and Samad, Farishah Nur Abdul and Isahak, Ilina (2021) The effectiveness of various gargle formulations and salt water against SARS-CoV-2. Scientific Reports, 11 (1). ISSN 2045-2322, DOI https://doi.org/10.1038/s41598-021-99866-w.

Full text not available from this repository.

Abstract

The COVID-19 is difficult to contain due to its high transmissibility rate and a long incubation period of 5 to 14 days. Moreover, more than half of the infected patients were young and asymptomatic. Virus transmission through asymptomatic patients is a major challenge to disease containment. Due to limited treatment options, preventive measures play major role in controlling the disease spread. Gargling with antiseptic formulation may have potential role in eliminating the virus in the throat. Four commercially available mouthwash/gargle formulations were tested for virucidal activity against SARS-CoV-2 in both clean (0.3 g/l BSA) and dirty (0.3 g/l BSA + 3 mL/L human erythrocytes) conditions at time points 30 and 60 s. The virus was isolated and propagated in Vero E6 cells. The cytotoxicity of the products to the Vero E6 was evaluated by kill time assay based on the European Standard EN14476:2013/FprA1:2015 protocol. Virus titres were calculated as 50% tissue culture infectious dose (TCID50/mL) using the Spearman-Karber method. A reduction in virus titer of 4 log(10) corresponds to an inactivation of >= 99.99%. Formulations with cetylperidinium chloride, chlorhexidine and hexitidine achieved > 4 log10 reduction in viral titres when exposed within 30 s under both clean and dirty conditions. Thymol formulations achieved only 0.5 log(10) reduction in viral titres. In addition, salt water was not proven effective. Gargle formulations with cetylperidinium chloride, chlorhexidine and hexetidine have great potential in reducing SAR-CoV-2 at the source of entry into the body, thus minimizing risk of transmission of COVID-19.

Item Type: Article
Funders: Universiti Sains Islam Malaysia[PPPI/COVID19_0120/FPSK/051000/15220], Ministry of Education, Malaysia for niche area research under the Higher Institution Centre of Excellence (HICoE) program[MO002-2019]
Uncontrolled Keywords: Coronavirus;COVID-19;Asymptomatic patients
Subjects: R Medicine
T Technology > T Technology (General)
Divisions: Deputy Vice Chancellor (Research & Innovation) Office > Tropical Infectious Diseases Research and Education Centre
Depositing User: Ms Zaharah Ramly
Date Deposited: 22 Jun 2022 06:26
Last Modified: 22 Jun 2022 06:26
URI: http://eprints.um.edu.my/id/eprint/34124

Actions (login required)

View Item View Item